Are BTK and PLCG2 mutations required and sufficient for ibrutinib resistance in Persistent lymphocytic leukemia?Long-term lymphocytic leukemia is a effectively-outlined lymphoid neoplasm with incredibly heterogeneous Organic and scientific behavior. The last decade is remarkably fruitful in novel results, elucidating many components of the pathogen